12-51063856-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_030809.3(CSRNP2):āc.1522C>Gā(p.Leu508Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000235 in 1,614,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030809.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSRNP2 | NM_030809.3 | c.1522C>G | p.Leu508Val | missense_variant | 5/5 | ENST00000228515.6 | NP_110436.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSRNP2 | ENST00000228515.6 | c.1522C>G | p.Leu508Val | missense_variant | 5/5 | 1 | NM_030809.3 | ENSP00000228515 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000107 AC: 27AN: 251228Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135782
GnomAD4 exome AF: 0.000246 AC: 359AN: 1461842Hom.: 0 Cov.: 31 AF XY: 0.000239 AC XY: 174AN XY: 727218
GnomAD4 genome AF: 0.000131 AC: 20AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 12, 2021 | The c.1522C>G (p.L508V) alteration is located in exon 5 (coding exon 4) of the CSRNP2 gene. This alteration results from a C to G substitution at nucleotide position 1522, causing the leucine (L) at amino acid position 508 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at